Search for: "Artzt v. Artzt"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
28 Oct 2024, 5:27 am
Case date: 26 March 2024 Casa number: 200.321.764/01 Court: Court of Appeal of Amsterdam A full summary of this case has been published on Kluwer IP Law More from our authors: Vissers Annotated European Patent Convention 2024 Edition by Kaisa Suominen, Nina Ferara, Peter de Lange, Andrew Rudge€ 105 International Handbook of Blockchain Law: A Guide to Navigating Legal and… [read post]
8 Oct 2024, 3:12 am
DivX v. [read post]
23 Sep 2024, 8:02 am
In 2014, the same Court had itself revoked certain claims relating to particular dosages for administering raloxifene, on the grounds that they were excluded from patentability (Paris Court of Appeal, 12 March 2014, Eli Lilly and company et al. v. [read post]
22 Oct 2024, 2:30 am
., (together, BioNTech/Pfizer) v CureVac SE. [read post]
9 Sep 2024, 12:39 pm
A notable example is the leading Johnson & Johnson v Scitech, in which the São Paulo State Court granted permanent injunction, material and moral damages for the infringement of surgical stapler IP rights. [read post]
12 Nov 2024, 4:00 am
The UK’s inventive step assessment is set out in Pozzoli Spa v BDMO SA & Anor [2007] EWCA Civ 588 and may be seen as a somewhat abbreviated assessment of inventive step compared with the EPO’s three-step more rigorous problem-solution approach. [read post]
12 Sep 2024, 2:15 am
This follows a similar decision by the same Local Division in Dyson v. [read post]
18 Oct 2024, 8:00 am
Putting to one side the escitalopram litigation, there has been only one other case in which a licence has been granted pursuant to section 223(9), namely the Commissioner’s decision in HRC Project Design Pty Ltd v Orford Pty Ltd (1997) 38 IPR 121 (HRC). [read post]
1 Nov 2024, 11:40 am
For example, the above quoted Section from Chapter H-V 2.7 cannot be found in the Guidelines of 2009 or of 2013. [read post]
